BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 23483478)

  • 1. Expression regulation and function of NLRC5.
    Yao Y; Qian Y
    Protein Cell; 2013 Mar; 4(3):168-75. PubMed ID: 23483478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLRC5 regulates MHC class I antigen presentation in host defense against intracellular pathogens.
    Yao Y; Wang Y; Chen F; Huang Y; Zhu S; Leng Q; Wang H; Shi Y; Qian Y
    Cell Res; 2012 May; 22(5):836-47. PubMed ID: 22491475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of the NOD-Like Receptor NLRC5 Results in Decreased CD8
    Lupfer CR; Stokes KL; Kuriakose T; Kanneganti TD
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28615208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance.
    Vijayan S; Sidiq T; Yousuf S; van den Elsen PJ; Kobayashi KS
    Immunogenetics; 2019 Mar; 71(3):273-282. PubMed ID: 30706093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Major Histocompatibility Complex Class I-Related Functions of NLRC5.
    Chelbi ST; Dang AT; Guarda G
    Adv Immunol; 2017; 133():89-119. PubMed ID: 28215281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NLRC5: a newly discovered MHC class I transactivator (CITA).
    Meissner TB; Li A; Kobayashi KS
    Microbes Infect; 2012 Jun; 14(6):477-84. PubMed ID: 22209772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRC5 deficiency has a moderate impact on immunodominant CD8
    Sun T; Ferrero RL; Girardin SE; Gommerman JL; Philpott DJ
    Immunol Cell Biol; 2019 Jul; 97(6):552-562. PubMed ID: 30768806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NLRC5/MHC class I transactivator is a target for immune evasion in cancer.
    Yoshihama S; Roszik J; Downs I; Meissner TB; Vijayan S; Chapuy B; Sidiq T; Shipp MA; Lizee GA; Kobayashi KS
    Proc Natl Acad Sci U S A; 2016 May; 113(21):5999-6004. PubMed ID: 27162338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NLRC5 deficiency selectively impairs MHC class I- dependent lymphocyte killing by cytotoxic T cells.
    Staehli F; Ludigs K; Heinz LX; Seguín-Estévez Q; Ferrero I; Braun M; Schroder K; Rebsamen M; Tardivel A; Mattmann C; MacDonald HR; Romero P; Reith W; Guarda G; Tschopp J
    J Immunol; 2012 Apr; 188(8):3820-8. PubMed ID: 22412192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC class I transactivator NLRC5 in host immunity, cancer and beyond.
    Cho SX; Vijayan S; Yoo JS; Watanabe T; Ouda R; An N; Kobayashi KS
    Immunology; 2021 Mar; 162(3):252-261. PubMed ID: 32633419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes.
    Meissner TB; Li A; Biswas A; Lee KH; Liu YJ; Bayir E; Iliopoulos D; van den Elsen PJ; Kobayashi KS
    Proc Natl Acad Sci U S A; 2010 Aug; 107(31):13794-9. PubMed ID: 20639463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of zebrafish NLRC5 in antiviral response and transcriptional regulation of MHC related genes.
    Wu XM; Hu YW; Xue NN; Ren SS; Chen SN; Nie P; Chang MX
    Dev Comp Immunol; 2017 Mar; 68():58-68. PubMed ID: 27876605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced TLR-induced NF-κB signaling and type I interferon responses in NLRC5 deficient mice.
    Tong Y; Cui J; Li Q; Zou J; Wang HY; Wang RF
    Cell Res; 2012 May; 22(5):822-35. PubMed ID: 22473004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of class I major histocompatibility complex (MHC) by nucleotide-binding domain, leucine-rich repeat-containing (NLR) proteins.
    Robbins GR; Truax AD; Davis BK; Zhang L; Brickey WJ; Ting JP
    J Biol Chem; 2012 Jul; 287(29):24294-303. PubMed ID: 22645137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The balance between nuclear import and export of NLRC5 regulates MHC class I transactivation.
    Zhu B; Ouda R; An N; Tanaka T; Kobayashi KS
    J Biol Chem; 2024 May; 300(5):107205. PubMed ID: 38519032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal NLRC5 regulates MHC class I expression in Neuro-2a cells and also during hippocampal development.
    Li P; Shen Y; Cui P; Hu Y; Zhang Y; Miao F; Zhang A; Zhang J
    J Neurochem; 2020 Jan; 152(2):182-194. PubMed ID: 31549732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLRC5 cooperates with the RFX transcription factor complex to induce MHC class I gene expression.
    Meissner TB; Liu YJ; Lee KH; Li A; Biswas A; van Eggermond MC; van den Elsen PJ; Kobayashi KS
    J Immunol; 2012 May; 188(10):4951-8. PubMed ID: 22490869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NLRC5 regulates expression of MHC-I and provides a target for anti-tumor immunity in transmissible cancers.
    Ong CEB; Patchett AL; Darby JM; Chen J; Liu GS; Lyons AB; Woods GM; Flies AS
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1973-1991. PubMed ID: 33797607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRC5 exclusively transactivates MHC class I and related genes through a distinctive SXY module.
    Ludigs K; Seguín-Estévez Q; Lemeille S; Ferrero I; Rota G; Chelbi S; Mattmann C; MacDonald HR; Reith W; Guarda G
    PLoS Genet; 2015 Mar; 11(3):e1005088. PubMed ID: 25811463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nucleotide-binding domain of NLRC5 is critical for nuclear import and transactivation activity.
    Meissner TB; Li A; Liu YJ; Gagnon E; Kobayashi KS
    Biochem Biophys Res Commun; 2012 Feb; 418(4):786-91. PubMed ID: 22310711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.